Search

everythinglearnresearchcommunity

for

Search:↓

Children with alopecia areata have more exclamation mark hairs and fewer yellow dots than adults.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Alopecia areata is hard to treat, but new targeted therapies show promise.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Androgenetic alopecia is more common in Saudi men than women.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Thyroid issues can cause alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Enzymes called PADIs play a key role in hair growth and loss.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Keloid scars can form after hair transplant surgery and should be prevented and treated early.